看來載入頁面時發生了錯誤.
我們的團隊已收到通知,但若此問題持續,請透過電郵支援widget工具聯絡我們。
Metrics | Range | Conclusion |
---|---|---|
Selected LTM Ps Multiple | 0.2x - 0.2x | 0.2x |
Selected Fwd Ps Multiple | 0.2x - 0.2x | 0.2x |
Fair Value | ₹20.13 - ₹22.25 | ₹21.19 |
Upside | 50.9% - 66.8% | 58.8% |
Benchmarks | Ticker | Full Ticker |
---|---|---|
Morepen Laboratories Limited | 50,028,800.0% | BSE:500288 |
Supriya Lifescience Limited | 54,343,400.0% | BSE:543434 |
SMS Pharmaceuticals Limited | 53,281,500.0% | BSE:532815 |
Shilpa Medicare Limited | 53,054,900.0% | BSE:530549 |
Anuh Pharma Limited | 50,626,000.0% | BSE:506260 |
Ind-Swift Limited | - | NSEI:INDSWFTLTD |
Select Price / LTM Sales Ratio | ||||||||
Benchmark Companies | ||||||||
500288 | 543434 | 532815 | 530549 | 506260 | INDSWFTLTD | |||
BSE:500288 | BSE:543434 | BSE:532815 | BSE:530549 | BSE:506260 | NSEI:INDSWFTLTD | |||
Historical Sales Growth | ||||||||
5Y CAGR | 17.1% | 15.1% | 8.7% | 9.5% | 15.1% | 11.2% | ||
3Y CAGR | 12.4% | 13.4% | 8.0% | 8.5% | 14.4% | 11.8% | ||
Latest Twelve Months | 8.6% | 20.9% | 27.3% | 11.0% | -2.1% | 7.0% | ||
Historical Net Income Profit Margin | ||||||||
5 Year Average Margin | 5.7% | 24.3% | 7.1% | 6.9% | 6.9% | -0.9% | ||
Prior Fiscal Year | 2.7% | 19.5% | -1.4% | -3.1% | 6.9% | 6.3% | ||
Latest Fiscal Year | 5.7% | 20.9% | 7.0% | 2.8% | 9.3% | 2.8% | ||
Latest Twelve Months | 7.1% | 26.0% | 8.5% | 7.1% | 8.0% | 12.7% | ||
Current Trading Multiples | ||||||||
EV / LTM EBITDA | 14.0x | 23.5x | 16.4x | 20.6x | 12.3x | 19.5x | ||
Price / LTM Sales | 1.5x | 8.9x | 2.4x | 4.7x | 1.3x | 0.1x | ||
LTM P/E Ratio | 21.6x | 34.4x | 27.9x | 66.5x | 15.7x | 1.1x | ||
Low | Mid | High | ||||||
Benchmark LTM P/S Ratio | 1.3x | 2.4x | 8.9x | |||||
Historical LTM P/S Ratio | 0.0x | 0.1x | 0.2x | |||||
Selected Price / Sales Multiple | 0.2x | 0.2x | 0.2x | |||||
(x) LTM Sales | 5,058 | 5,058 | 5,058 | |||||
(=) Equity Value | 1,087 | 1,145 | 1,202 | |||||
(/) Shares Outstanding | 54.2 | 54.2 | 54.2 | |||||
Implied Value Range | 20.08 | 21.13 | 22.19 | |||||
FX Rate: INR/INR | 1.0 | 1.0 | 1.0 | Market Price | ||||
Implied Value Range (Trading Cur) | 20.08 | 21.13 | 22.19 | 13.34 | ||||
Upside / (Downside) | 50.5% | 58.4% | 66.3% |
Equity Value | |||||||
Benchmark Companies | |||||||
(in millions) | 500288 | 543434 | 532815 | 530549 | 506260 | INDSWFTLTD | |
Value of Common Equity | 26,011 | 59,521 | 17,917 | 58,027 | 7,524 | 723 | |
(/) Shares Outstanding | 548.0 | 80.5 | 84.7 | 86.8 | 50.1 | 54.2 | |
Implied Stock Price | 47.47 | 739.55 | 211.65 | 668.50 | 150.15 | 13.34 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 47.47 | 739.55 | 211.65 | 668.50 | 150.15 | 13.34 | |
Trading Currency | INR | INR | INR | INR | INR | INR | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |